Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press143610.17650/1726-9776-2021-17-4-129-135REVIEWSОБЗОРЫProspects of texture analysis in radiological imaging for diagnosis of renal parenchyma tumorВозможности текстурного анализа лучевых методов визуализации в диагностике образований паренхимы почкиhttps://orcid.org/0000-0002-9586-7859GorduladzeD. N.ГордуладзеД. Н.
Russian Federation

Build. 1, 2 Bol'shaya Pirogovskaya St., Moscow 119435.

119435 Москва, ул. Большая Пироговская, 2, стр. 1.

https://orcid.org/0000-0001-6419-0155SirotaE. S.СиротаЕ. С.
Russian Federation

Evgeniy S. Sirota.

Build. 1, 2 Bol'shaya Pirogovskaya St., Moscow 119435; 7а Marshla Biryuzova St., Odintsovo 143000.

Сирота Евгений Сергеевич - врач-уролог.

119435 Москва, ул. Большая Пироговская, 2, стр. 1; 143003 Одинцово, ул. Маршала Бирюзова, 7а.

essirota@mail.ruRapoportL. M.РапопортЛ. М.
Russian Federation

Build. 1, 2 Bol'shaya Pirogovskaya St., Moscow 119435.

119435 Москва, ул. Большая Пироговская, 2, стр. 1.

GridinV. N.ГридинВ. Н.
Russian Federation

7а Marshla Biryuzova St., Odintsovo 143000.

143003 Одинцово, ул. Маршала Бирюзова, 7а.

https://orcid.org/0000-0002-3608-8759TsarichenkoD. G.ЦариченкоД. Г.
Russian Federation

Build. 1, 2 Bol'shaya Pirogovskaya St., Moscow 119435.

119435 Москва, ул. Большая Пироговская, 2, стр. 1.

https://orcid.org/0000-0001-6905-2464KuznetsovI. A.КузнецовИ. А.
Russian Federation

7а Marshla Biryuzova St., Odintsovo 143000.

143003 Одинцово, ул. Маршала Бирюзова, 7а.

https://orcid.org/0000-0002-5464-2733BochkaryovP. V.БочкаревП. В.
Russian Federation

7а Marshla Biryuzova St., Odintsovo 143000.

143003 Одинцово, ул. Маршала Бирюзова, 7а.

AlyaevYu. G.АляевЮ. Г.
Russian Federation

Build. 1, 2 Bol'shaya Pirogovskaya St., Moscow 119435.

119435 Москва, ул. Большая Пироговская, 2, стр. 1.

Institute of Urology and Human Reproductive Health, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)Институт урологии и репродуктивного здоровья человека ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский Университет)Design Information Technologies Center, Russian Academy of SciencesЦентр информационных технологий в проектировании Российской академии наук1012202117412913516042021121220212021https://oncourology.abvpress.ru/oncur/article/view/1436

This review outlines current trends in applying texture analysis for the treatment of patients with renal parenchyma tumor. The prospects of using radiomics in the diagnosis and treatment of patients with renal cell carcinoma are presented.

В настоящем обзоре изложены основные направления текстурного анализа в лечении пациентов с образованиями паренхимы почки, используемые в современной медицине. Представлены возможности применения радиомики в диагностике и лечении больных с почечно-клеточным раком.

texture analysismachine learningradiomics5P medicinemultispiral computed tomographymagnetic resonance imagingrenal tumorтекстурный анализмашинное обучениерадиомика5П-медицинамультиспиральная компьютерная томографиямагнитно-резонансная томографияопухоль почкиThe work was performed within the framework of the theme No. 0071-2019-0001.Работа выполнена в рамках темы № 0071-2019-0001.Wilhelm Konrad Roentgen-The Centennial of His Birth-Semicentennial of the X-Rays. JAMA 2020;323(15):1512. DOI: 10.1001/jama.2019.13400.Hounsfield G.N. Computerized transverse axial scanning (tomography): Part I. Description of system 1975. Br J Radiol 1973;68(815):H166-72.Pincock S. US and UK researchers share Nobel prize. Paul C. Lauterbur and Peter Mansfield share award for seminal work on MRI. Lancet 2003;362(9391):1203. DOI: 10.1016/s0140-6736(03)14557-6.Davnall F., Yip C.S.P., Ljungqvist G. et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012;3(6):573-89. DOI: 10.1007/s13244-012-0196-6.Haralick R.M., Shanmugam K., Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybern 1973;SMC-3(6):610-21. DOI: 10.1109/TSMC.1973.4309314.Aerts H.J.W.L. The potential of radiomic-based phenotyping in precisionmedicine a review. JAMA Oncol 2016;2(12):1636-42. DOI: 10.1001/jamaoncol.2016.2631.Lubner M.G., Smith A.D., Sandrasegaran K. et al. CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics 2017;37(5):1483-503. DOI: 10.1148/rg.2017170056.Blobel B., Ruotsalainen P., Brochhausen M. et al. Autonomous systems and artificial intelligence in healthcare transformation to 5p medicine - ethical challenges. Stud Health Technol Inform 2020;270:1089-93. DOI: 10.3233/SHTI200330.DeCastro G.J., McKiernan J.M. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am 2008;35(4):581-92. DOI: 10.1016/j.ucl.2008.07.005.Frank I., Blute M.L., Cheville J.C. et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003;170(6 Pt 1):2217-20. DOI: 10.1097/01.ju.0000095475.12515.5e.Zhou L., Zhang Z., Chen Y.C. et al. A deep learning-based radiomics model for differentiating benign and malignant renal tumors. Transl Oncol 2019;12(2):292-300. DOI: 10.1016/j.tranon.2018.10.012.Said D., Hectors S.J., Wilck E. et al. Characterization of solid renal neoplasms using MRI-based quantitative radiomics features. Abdom Radiol 2020;45(9):2840-50. DOI: 10.1007/s00261-020-02540-4.Uhlig J., Biggemann L., Nietert M.M. et al. Discriminating malignant and benign clinical T1 renal masses on computed tomography: a pragmatic radiomics and machine learning approach. Medicine 2020;99(16):e19725. DOI: 10.1097/MD.0000000000019725.Yap F.Y., Varghese B.A., Cen S.Y. et al. Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses. Eur Radiol 2021;31(2):1011-21. DOI: 10.1007/s00330-020-07158-0.Deng Y., Soule E., Samuel A. et al. CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade. Eur Radiol 2019;29(12):6922-9. DOI: 10.1007/s00330-019-06260-2.Erdim C., Yardimci A.H., Bektas C.T. et al. Prediction of benign and malignant solid renal masses: machine learning-based CT texture analysis. Acad Radiol 2020;27(10):1422-9. DOI: 10.1016/j.acra.2019.12.015.Xi I.L., Zhao Y., Wang R. et al. Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging. Clin Cancer Res 2020;26(8):1944-52. DOI: 10.1158/1078-0432.CCR-19-0374.Znaor A., Lortet-Tieulent J., Laversanne M. et al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 2015;67(3):519-30. DOI: 10.1016/j.eururo.2014.10.002.Cheville J.C., Lohse C.M., Zincke H. et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27(5):612-24. DOI: 10.1097/00000478-200305000-00005.Yu H.S., Scalera J., Khalid M. et al. Texture analysis as a radiomic marker for differentiating renal tumors. Abdom Radiol 2017;42(10):2470-8. DOI: 10.1007/s00261-017-1144-1.Zhang G.M.Y., Shi B., Xue H.D. et al. Can quantitative CT texture analysis be used to differentiate subtypes of renal cell carcinoma? Clin Radiol 2019;74(4):287-94. DOI: 10.1016/j.crad.2018.11.009.Duan C., Li N., Niu L. et al. CT texture analysis for the differentiation of papillary renal cell carcinoma subtypes. Abdom Radiol 2020;45(11):3860-8. DOI: 10.1007/s00261-020-02588-2.Wang W., Cao K.M., Jin S.M. et al. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol 2020;30(10):5738—47. DOI: 10.1007/s00330-020-06896-5.Fuhrman S., Lasky L.C., Limas C. Prognostic significance of morphologic parametrs in renal cell carcinoma. Am J Surg Pathol 1982;6(7):655-63. DOI: 10.1097/00000478-198210000-00007.Moch H., Cubilla A.L., Humphrey P.A. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs — part A: renal, penile, and testicular tumours. Eur Urol 2016;70(1):93-105. DOI: 10.1016/j.eururo.2016.02.029.Tsui K.H., Shvarts O., Smith R.B. et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163(4):1090-5. DOI: 10.1016/S0022-5347(05)67699-9.Feng Z., Shen Q., Li Y., Hu Z. CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma. Cancer Imaging 2019;19(1):6. DOI: 10.1186/s40644-019-0195-7.Goyal A., Razik A., Kandasamy D. et al. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study. Abdom Radiol 2019;44(10):3336-49. DOI: 10.1007/s00261-019-02122-z.Boos J., Revah G., Brook O.R. et al. CT intensity distribution curve (Histogram) analysis of patients undergoing antiangiogenic therapy for metastatic renal cell carcinoma. Am J Roentgenol 2017;209(2):W85-92. DOI: 10.2214/AJR.16.17651.Bharwani N., Miquel M.E., Powles T. et al. Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma. Br J Cancer 2014;110(3):616-24. DOI: 10.1038/bjc.2013.790.Ueno D., Yao M., Tateishi U. et al. Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course. BMC Cancer 2012;12:162. DOI: 10.1186/1471-2407-12-162.Antunes J., Viswanath S., Rusu M. et al. Radiomics analysis on FLT-PET/MRI for characterization of early treatment response in renal cell carcinoma: a proof-of-concept study. Transl Oncol 2016;9(2):155-62. DOI: 10.1016/j.tranon.2016.01.008.Goh V., Ganeshan B., Nathan P. et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 2011;261(1):165-71. DOI: 10.1148/radiol.11110264.